ALKERMES reported 2.41M in Interest Expense on Debt for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Interest Expense On Debt Change
Amgen AMGN:US $ 281M 4M
Biogen BIIB:US $ 56.4M 8.3M
Biomarin Pharmaceutical BMRN:US $ 3.82M 0.01M
Bristol Myers Squibb BMY:US $ 330M 23M
Coherus Biosciences CHRS:US $ 5.75M 0.1M
Eli Lilly And LLY:US $ 86.9M 0.9M
Gilead Sciences GILD:US $ 256M 1M
Gw Pharmaceuticals GWPH:US $ 0.29M 0.02M
IONIS PHARMACEUT IONS:US $ 2.36M 0.06M
JAZZ PHA JAZZ:US $ 69.82M 41.24M
Nektar Therapeutics NKTR:US $ 13.09M 0.21M
Neurocrine Biosciences NBIX:US $ 6.2M 0.2M
Pfizer PFE:US $ 316M 20M
Regeneron Pharmaceuticals REGN:US $ 14.4M 0.2M
Revance Therapeutics RVNC:US $ 1.57M 9K
Teva Pharmaceutical Industries TEVA:US $ 240M 1M
Vertex Pharmaceuticals VRTX:US $ 15.48M 0.2M
Zogenix ZGNX:US $ 3.79M 0.05M